Mitsubishi UFJ Securities’s Bristol-Myers Squibb BMY Stock Holding History

Mitsubishi UFJ Securities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-450	Closed	-$28K	–	118
2018 Q3	$28K	Hold	450	–	–	0.09%	132
2018 Q2	$25K	Sell	450 -470	-51%	-$25.4K	0.09%	129
2018 Q1	$58K	Buy	920 +470	+104%	+$30.2K	0.22%	97
2017 Q4	$28K	Sell	450 -450	-50%	-$28.1K	0.12%	136
2017 Q3	$57K	Hold	900	–	–	0.27%	83
2017 Q2	$50K	Buy	+900	New	+$49K	0.27%	85
2017 Q1	–	Sell	-1,520	Closed	-$89K	–	246
2016 Q4	$89K	Buy	1,520 +1,300	+591%	+$71.1K	0.51%	43
2016 Q3	$12K	Sell	220 -1,060	-83%	-$68.1K	0.06%	158
2016 Q2	$94K	Sell	1,280 -10	-0.8%	-$707	0.17%	76
2016 Q1	$82K	Sell	1,290 -1,040	-45%	-$65.6K	0.11%	84
2015 Q4	$160K	Buy	2,330 +450	+24%	+$29.7K	0.24%	44
2015 Q3	$111K	Buy	1,880 +1,230	+189%	+$78K	0.78%	19
2015 Q2	$43K	Sell	650 -700	-52%	-$46.1K	0.29%	70
2015 Q1	$87K	Buy	+1,350	New	+$84.5K	0.23%	24

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Mitsubishi UFJ Securities's BMY Position: Q4 2018 in Review

Mitsubishi UFJ Securities sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 450 shares — an estimated $28K sold.

Mitsubishi UFJ Securities first reported a position in BMY in Q1 2015 and held it in 14 quarters. The position peaked at $160K in Q4 2015. 1,765 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Mitsubishi UFJ Securities reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
Mitsubishi UFJ Securities sold 450 Bristol-Myers Squibb shares in Q4 2018, an estimated $28K.
Mitsubishi UFJ Securities first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 14 quarters.
Mitsubishi UFJ Securities's Bristol-Myers Squibb position peaked at $160K in Q4 2015.
1,765 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Mitsubishi UFJ Securities's 13F filing for Q4 2018, filed 14 Feb 2019.